Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-16

Clinical Trial Update: BHV-7000 Acute Treatment of Bipolar Mania [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update notes the phase 2 and phase 3 studies of BHV-7000 for acute treatment of bipolar mania have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BHV-7000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Bipolar Disorder | Phase 2, Phase 3 | Status: COMPLETED